Femasys Inc. FEMY shares are up more than 14% on Monday and have gained more than 900% over the last five days. Here's a look at what's going on:
What To Know:
HC Wainwright & Co. analyst Emily Bodnar maintained Femasys with a Buy rating and raised the price target from $5 to $13 on Friday.
Femasys also announced last week that it has activated enrollment for its FemBloc trial to investigate a permanent birth control candidate.
Shares of FEMY are moving higher on very heavy trading volume. According to data from Benzinga Pro, more than 67 million shares have been traded in the session, compared to the stock's 100-day average of 9.709 million shares.
Related News: What's Going On With MicroStrategy Inc Stock?
FEMY Price Action: According to Benzinga Pro, Femasys shares are up 14% at $3.40 at the time of publication.
Image: 51581 from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
